IL150679A0 - Use of mia in immunotherapy - Google Patents

Use of mia in immunotherapy

Info

Publication number
IL150679A0
IL150679A0 IL15067901A IL15067901A IL150679A0 IL 150679 A0 IL150679 A0 IL 150679A0 IL 15067901 A IL15067901 A IL 15067901A IL 15067901 A IL15067901 A IL 15067901A IL 150679 A0 IL150679 A0 IL 150679A0
Authority
IL
Israel
Prior art keywords
mia
immunotherapy
Prior art date
Application number
IL15067901A
Other languages
English (en)
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of IL150679A0 publication Critical patent/IL150679A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Mycology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL15067901A 2000-03-23 2001-03-15 Use of mia in immunotherapy IL150679A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00201063 2000-03-23
PCT/EP2001/002991 WO2001070253A1 (en) 2000-03-23 2001-03-15 Use of mia in immunotherapy

Publications (1)

Publication Number Publication Date
IL150679A0 true IL150679A0 (en) 2003-02-12

Family

ID=8171248

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15067901A IL150679A0 (en) 2000-03-23 2001-03-15 Use of mia in immunotherapy

Country Status (19)

Country Link
US (1) US20030091583A1 (hu)
EP (1) EP1267907A1 (hu)
JP (1) JP2003527435A (hu)
KR (1) KR20020089404A (hu)
CN (1) CN1418105A (hu)
AR (1) AR027694A1 (hu)
AU (1) AU783170B2 (hu)
BR (1) BR0109455A (hu)
CA (1) CA2399028A1 (hu)
CZ (1) CZ20023187A3 (hu)
HU (1) HUP0300997A2 (hu)
IL (1) IL150679A0 (hu)
MX (1) MXPA02008889A (hu)
NO (1) NO20024458L (hu)
NZ (1) NZ520346A (hu)
PL (1) PL358132A1 (hu)
RU (1) RU2002128351A (hu)
SK (1) SK13692002A3 (hu)
WO (1) WO2001070253A1 (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040076965A1 (en) * 2002-10-16 2004-04-22 Bosserhoff Anja Katrin MIA-2 protein
US8026354B2 (en) * 2005-11-23 2011-09-27 Institut Pasteur Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use
BRPI0706575B8 (pt) * 2006-01-13 2021-05-25 Univ Indiana Res & Tech Corp uso colágeno de tipo v ou um componente antigênico do mesmo, e, método para identificar um paciente em espera de transplante de pulmão para um risco aumentado de rejeição de tecido de órgão transplantado.
EP2307048A4 (en) * 2008-07-16 2012-02-29 Baylor Res Inst HIV VACCINE BASED ON TARGETING OF MAXIMIZED GAG AND NEF ON DENDRITIC CELLS
CN102869679B (zh) * 2010-04-27 2015-11-25 Scil技术股份有限公司 稳定的水性mia/cd-rap制剂
ITRM20110134A1 (it) * 2011-03-22 2012-09-23 Matteo Bordignon Inibitori di mia (attività inibitoria melanoma) per identificare, prevenire e curare la vitiligine
AU2013234815B2 (en) * 2012-03-23 2017-06-22 The University Of Queensland Immunomodulatory agent and uses therefor
ITRM20120339A1 (it) * 2012-07-16 2014-01-17 Matteo Bordignon Uso di mia (attività inibitoria melanoma) per il trattamento della iper-pigmentazione cutanea e per lo sbiancamento cosmetico della pelle
CN116327971A (zh) * 2023-03-02 2023-06-27 暨南大学附属第一医院（广州华侨医院） 一种靶向cd74+促炎型巨噬细胞的药物载体及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE185152T1 (de) * 1993-07-20 1999-10-15 Roche Diagnostics Gmbh Melanom-inhibierendes protein
EP0972022A2 (en) * 1997-01-21 2000-01-19 Human Genome Sciences, Inc. Polynucleotides and polypeptides encoding receptors
DE59810255D1 (de) * 1997-10-16 2004-01-08 Scil Technology Holding Gmbh Nachweis von Knorpelerkrankungen mit MIA

Also Published As

Publication number Publication date
KR20020089404A (ko) 2002-11-29
NZ520346A (en) 2004-07-30
US20030091583A1 (en) 2003-05-15
RU2002128351A (ru) 2004-03-27
AU783170B2 (en) 2005-09-29
BR0109455A (pt) 2003-06-03
AR027694A1 (es) 2003-04-09
MXPA02008889A (es) 2003-04-25
AU4247601A (en) 2001-10-03
HUP0300997A2 (hu) 2003-07-28
PL358132A1 (en) 2004-08-09
JP2003527435A (ja) 2003-09-16
CN1418105A (zh) 2003-05-14
NO20024458D0 (no) 2002-09-18
WO2001070253A1 (en) 2001-09-27
CA2399028A1 (en) 2001-09-27
NO20024458L (no) 2002-09-18
CZ20023187A3 (cs) 2003-01-15
EP1267907A1 (en) 2003-01-02
WO2001070253A8 (en) 2003-03-20
SK13692002A3 (sk) 2003-02-04

Similar Documents

Publication Publication Date Title
HUP0200549A3 (en) Apomorphine and sildenafil composition and their use
IL184144A0 (en) Intermediates useful in the preparaiton of 2-aminocarbonyl-9h-purine derivatives
HK1076686A1 (en) Smoking article and use thereof
AU3651002A (en) Seed-preferred regulatory elements and uses thereof
HK1068555A1 (en) New formulations and use thereof
EP1257565A4 (en) DERIVED FROM MUCIN-1 ANTIGENE AND ITS USE IN IMMUNOTHERAPY
AU1334602A (en) Osteopontin-coated surfaces and methods of use
IL159872A0 (en) Gmg-2 polypeptides and their use
IL150679A0 (en) Use of mia in immunotherapy
AU2002363938A8 (en) Methods and use of motoneuronotropic factors
GB0200204D0 (en) Cosmetic and related preparations
GB0026134D0 (en) Peptides and their use
HUP0303936A3 (en) Novel composition and use
EP1367123A4 (en) NEUROTONIN AND ITS USE
EP1541677A4 (en) NEW PROTEINS AND USE THEREOF
EP1577322A4 (en) NEW PROTEINS AND THEIR USE
EP1392460A4 (en) AMINOSILANOL HYDROFLUORIDES AND THEIR USE
GB0200843D0 (en) Benzodioxinopyrroles their preparation and use
PL359171A1 (en) Composition and use
AU2003263224A8 (en) Polishing composition and methods
EP1548106A4 (en) PROTEINS OF HUMAN ORIGIN FORMING A DOMAIN AND THEIR USE
AUPQ536900A0 (en) Antigens and their use in immunotherapy
GB0218616D0 (en) Cosmetic article and related methods
GB0218614D0 (en) Cosmetic article and related methods
GB0218609D0 (en) Cosmetic article and related methods